Stay updated on Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial page.

Latest updates to the Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial page
- Check6 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.0%
- Check14 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check21 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.8%
- Check28 days agoNo Change Detected
- Check49 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check64 days agoChange DetectedThe webpage has been updated to include new identifiers and collaborators related to a clinical trial for hormone-resistant metastatic prostate cancer, while significant details about the trial's objectives and treatment protocols have been removed.SummaryDifference48%
- Check71 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
Stay in the know with updates to Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial page.